Drug to treat canine lymphoma gets FDA approvalJanuary 3, 2017VetDC, Inc., a veterinary cancer therapeutics company, today announced that the U.S. Food and Drug Administration’s Center for Veterinary Medicine has granted a conditional approval of Tanovea™-CA1 (rabacfosadine for injection) for the treatment of lymphoma in dogs.
SPONSORED CONTENTGive your patients FAST diarrhea reliefProbiotics or nutrition? Prioritize Hill's Prescription Diet GIB nutrition clinically shown to resolve diarrhea in as little as 24 hours. + Learn More